| Cardiovascular Care | Pre-Clinical | Phase I | Phase II | Phase III | Filed | Approved | ||
|---|---|---|---|---|---|---|---|---|
| Angiomax® (bivalirudin) (U.S.) | ||||||||
| Angiox® (bivalirudin) (EU) | ||||||||
| Inclisiran | ||||||||
| Surgery and Perioperative Care | Pre-Clinical | Phase I | Phase II | Phase III | Filed | Approved | ||
| Ionsys® (fentanyl iontophoretic transdermal system) (U.S.) |
||||||||
| Ionsys® (fentanyl iontophoretic transdermal system) (EU) |
||||||||
| MDCO-700 | ||||||||
| Infectious Disease Care | Pre-Clinical | Phase I | Phase II | Phase III | Filed | Approved | ||
| Orbactiv® (oritavancin) |
||||||||
| Minocin® (minocycline) for Injection |
||||||||
| Meropenem-vaborbactam | ||||||||